Retour sur lavenir.net
   SOLVAY 26.720 € (+1,14 %)     ONTEX GROUP 2.190 € (+0,92 %)     AB INBEV 69.740 € (+0,14 %)     COLRUYT 37.760 € (+1,56 %)     NYXOAH 1.420 € (-4,83 %)     KINEPOLIS GROUP 37.550 € (+1,21 %)     SHURGARD 26.250 € (+0,96 %)     CIE BOIS SAUVAGE 303.000 € (0,00 %)     VAN DE VELDE 30.000 € (0,00 %)     BANQUP GROUP 2.100 € (-1,41 %)     CFE 12.500 € (-0,40 %)     WDP 21.920 € (+0,55 %)     IBA 16.840 € (-1,75 %)     ASCENCIO 51.800 € (+0,19 %)     PROXIMUS 6.130 € (-0,97 %)     BARCO 8.310 € (-0,36 %)     VASTNED 29.750 € (-0,34 %)     ACKERMANS V.HAAREN 268.800 € (+0,45 %)     XIOR 27.500 € (-0,72 %)     EVS 27.150 € (0,00 %)     VIOHALCO 18.200 € (+2,59 %)     SIPEF 89.800 € (-0,44 %)     WHAT'S COOKING GP 141.000 € (0,00 %)     AGEAS 71.500 € (+0,78 %)     JENSEN-GROUP 81.400 € (+0,25 %)     D'IETEREN GROUP 169.600 € (-1,05 %)     AEDIFICA 69.150 € (+0,44 %)     ECONOCOM GROUP 1.480 € (+4,59 %)     LOTUS BAKERIES 10 940.000 € (-0,55 %)     KBC 121.550 € (+0,83 %)     GBL 77.900 € (+0,06 %)     KBC ANCORA 85.600 € (+1,18 %)     ARGENX SE 761.200 € (+0,21 %)     BPOST 1.608 € (-0,12 %)     BELYSSE GROUP 0.534 € (+4,30 %)     BREDERODE 103.200 € (0,00 %)     ACCENTIS 0.027 € (+5,88 %)     DECEUNINCK 2.195 € (-1,13 %)     DEME GROUP 171.400 € (+2,02 %)     AGFA-GEVAERT 0.408 € (-1,57 %)     SOFINA 226.800 € (-0,35 %)     EXMAR 11.450 € (+1,33 %)     ONWARD MEDICAL 2.480 € (-1,98 %)     HOME INVEST BE. 19.060 € (+0,42 %)     ELIA GROUP 139.800 € (+0,79 %)     CENERGY 21.060 € (-2,05 %)     CMB.TECH 13.880 € (+1,91 %)     WERELDHAVE BELGIUM 53.200 € (+1,53 %)     ORANGE BELGIUM 21.500 € (0,00 %)     GIMV 44.800 € (-1,54 %)     CAMPINE 219.000 € (+3,79 %)     MELEXIS 74.350 € (-1,59 %)     FAGRON 23.900 € (-0,42 %)     FLUXYS BELGIUM D 20.000 € (+2,56 %)     AZELIS GROUP 10.970 € (+5,38 %)     UCB 232.500 € (-1,32 %)     MONTEA 67.400 € (+0,75 %)     EKOPAK 3.500 € (-5,41 %)     SYENSQO 68.000 € (+0,67 %)     VGP 82.100 € (+1,11 %)  
   PROSUS 39.190 € (-0,75 %)     INPOST 15.490 € (+0,13 %)     WORLDLINE 9.519 € (-1,07 %)     CARREFOUR 16.640 € (+0,15 %)     VEOLIA ENVIRON. 37.460 € (+1,38 %)     COMPAGNIE ODET 1 438.000 € (-1,10 %)     CSG 14.056 € (+6,23 %)     ASML HOLDING 1 555.800 € (+0,97 %)     LEGRAND 142.000 € (+1,97 %)     PHILIPS KON 23.010 € (-4,48 %)     ADP 109.100 € (-2,06 %)     AALBERTS NV 40.000 € (+1,01 %)     V LANSCHOT KEMPEN 67.300 € (+0,67 %)     CRCAM SUD R.A.CCI 217.000 € (-0,46 %)     SHELL PLC 36.865 € (+0,99 %)     TECHNIP ENERGIES 32.980 € (-0,30 %)     NN GROUP 77.480 € (+1,81 %)     RENAULT 25.840 € (-1,30 %)     CAPGEMINI 90.140 € (-1,62 %)     APERAM 46.860 € (-0,68 %)     ARCELORMITTAL SA 58.720 € (+1,17 %)     DSM FIRMENICH AG 84.940 € (+1,34 %)     ING GROEP N.V. 28.745 € (+1,14 %)     BE SEMICONDUCTOR 251.600 € (+1,86 %)     HEINEKEN 75.840 € (+0,05 %)     AHOLD DEL 36.120 € (+1,46 %)     UNILEVER 53.530 € (-0,50 %)     RELX 28.800 € (-1,44 %)     KPN KON 4.345 € (+0,25 %)     WOLTERS KLUWER 61.260 € (-1,89 %)     IMCD 91.580 € (+6,24 %)     AEGON 7.836 € (+1,79 %)     SBM OFFSHORE 32.100 € (-0,74 %)     MAGNUM 16.306 € (+0,27 %)     QUADIENT 11.960 € (-0,83 %)     SOITEC 102.750 € (+5,00 %)     PLANISWARE 20.650 € (-1,67 %)     SYNERGIE 28.100 € (-0,35 %)     AKZO NOBEL 57.340 € (-0,24 %)     AIR LIQUIDE 178.520 € (+1,01 %)     PERNOD RICARD 63.480 € (-1,15 %)     ASM INTERNATIONAL 927.600 € (+4,27 %)     SPIE 47.900 € (+0,42 %)     NANOBIOTIX 36.200 € (+3,61 %)     FORVIA 8.980 € (-2,79 %)     LVMH 482.950 € (-1,74 %)     HEIJMANS KON 96.150 € (-0,77 %)     SAINT GOBAIN 74.620 € (-0,35 %)     VALERIO TX 0.429 € (+7,25 %)     ADYEN 827.500 € (-1,92 %)     MICHELIN 34.180 € (-1,58 %)     LIGHTON 5.060 € (-4,71 %)     BENETEAU 6.080 € (-0,82 %)     KERING 244.250 € (-2,44 %)     TOTALENERGIES 71.200 € (+1,11 %)     IPSOS 35.360 € (+0,57 %)     BNP PARIBAS ACT.A 102.320 € (+1,39 %)     CAFOM 13.300 € (-3,62 %)     ESSILORLUXOTTICA 165.150 € (-2,51 %)     MAROC TELECOM 8.800 € (0,00 %)  
News Réglementées
28/04/2023 00:10

Route1 Announces Q4 and Fiscal Year 2022 Financial Results

TORONTO, ON / ACCESSWIRE / April 27, 2023 / Route1 Inc. (OTCQB:ROIUF) and (TSXV:ROI) (the "Company" or "Route1"), an advanced North American provider of data-centric business empowerment solutions, today reported its financial results for the three and twelve-month periods ended December 31, 2022.

Fiscal Year 2022 (FY 2022)

The Company's operating results for fiscal year 2021 with comparatives are as follows:

In 000s of CAD dollars
FY 2022FY 2021FY 2020FY 2019FY 2018
Revenue





Services
6,1949,7029,5747,8346,209
Device
15,83017,43220,03816,16919,972
Other
2113794749
Total Revenue
22,04527,27129,70724,01026,231
Cost of revenue
14,46216,44618,63514,97818,732
Gross profit
7,58310,82511,0729,0327,499
Operating expenses
7,6459,8129,9358,2146,892
Operating profit 1
(62)1,0131,137818607
Patent litigation 2
--1,6101,289841
Total other expenses 3, 4
1,6567911,23482200
Net income (loss)
(1,718)222(1,707)(554)(434)

1 Before stock-based compensation

2 For FY 2020, the Company incurred expenses for patent litigation net of the reversal of an accounting liability reflecting the funds the Company received from its litigation funding agreement. The Company has concluded the litigation with VMWare in both Canada and the United States and will incur no additional expense for this litigation.

3 Includes gain on litigation, gain or loss on asset disposal, stock-based compensation expense, interest expense, income tax recovery, foreign exchange loss or gain, other expenses and acquisition expense.

4 For FY 2022, the Company wrote down its deferred tax asset and liabilities with a net impact of ($1,141).

Fourth Quarter 2022 (Q4 2022)

"Route1's fourth quarter of 2022 net income was negatively impacted by our decision to remove deferred taxes assets and liabilities from the Company's balance sheet in the net amount of approximately CAD $1.1 million. It had no cash consequence. Further, the accounting decision has no impact on our ability to use our $11.8 million in Canadian operating tax losses that are being carried forward to reduce or eliminate cash tax obligations annually on our taxable operating income", said Tony Busseri, Route1's President and CEO.

The Company's operating results for Q4 2022 with comparatives are as follows:

Statement of operations
In 000s of CAD dollars
Q4
2022
Q3
2022
Q2
2022
Q1
2022
Q4
2021
Revenue
Subscription and services
1,1031,3261,8541,9111,977
Devices and appliances
2,2795,5195,2512,7815,022
Other
629336
Total revenue
3,3886,8477,1144,6957,035
Cost of revenue
2,0324,8425,0152,5724,660
Gross profit
1,3562,0052,0992,1232,375
Operating expenses
1,8591,8021,9722,0122,383
Operating profit 1
(503)203127111(8)
Total other expenses 2, 3
1,223139183112307
Net income (loss)
(1,726)64(56)(1)(315)

1 Before stock-based compensation

2 Includes gain on litigation, gain or loss on asset disposal, stock-based compensation expense, interest expense, income tax recovery, foreign exchange loss or gain, other expenses and acquisition expense.

3 For Q4 2022, the Company wrote down its deferred tax asset and liabilities with a net impact of ($1,141).

Subscription and services revenue
in 000s of CAD dollars
Q4
2022
Q3
2022
Q2
2022
Q1
2022
Q4
2021
Application software
4758041,4021,4831,504
Technology as a service (TaaS)
----50
Other services
628522452428423
Total
1,1031,3261,8541,9111,977
Other services revenue
in 000s of CAD dollars
Q4
2022
Q3
2022
Q2
2022
Q1
2022
Q4
2021
Technology life-cycle maintenance and support
300275214209175
Professional services
328246238219248
Total
628521452428423
Adjusted EBITDA
in 000s of CAD dollars
Q4
2022
Q3
2022
Q2
2022
Q1
2022
Q4
2021
Adjusted EBITDA 3
(142)543459446341
Amortization
361340332335348
Operating profit
(503)203127111(8)

3 Adjusted EBITDA is defined as earnings before interest, income taxes, depreciation and amortization, stock-based compensation, patent litigation, restructuring and other costs. Adjusted EBITDA does not have any standardized meaning prescribed under IFRS and is therefore unlikely to be comparable to similar measures presented by other companies. Adjusted EBITDA allows Route1 to compare its operating performance over time on a consistent basis.



Balance sheet extracts
In 000s of CAD dollars
Dec 31
2022
Sep 30
2022
Jun 30
2022
Mar 31
2022
Dec 31
2021
Cash
7910329948163
Total current assets

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière